Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity
Open Access
- 5 August 1991
- journal article
- Published by Wiley in FEBS Letters
- Vol. 287 (1-2), 39-41
- https://doi.org/10.1016/0014-5793(91)80011-q
Abstract
The hemorphins are opioid active peptides, which are enzymatically released from the beta‐chain of hemoglobin. In this paper we report an inhibitory effect of these peptides on angiotensin converting enzyme (ACE) activity, known to be involved in blood pressure regulation. The hemorphins were found to be quite stable in tissue extracts containing ACE, and their importance as naturally occurring ACE inhibitors is discussed.Keywords
This publication has 12 references indexed in Scilit:
- Isolation and characterization of a hemoglobin-derived opioid peptide from the human pituitary glandRegulatory Peptides, 1991
- Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophinEuropean Journal of Pharmacology, 1989
- Novel opioid peptides defived from hemoglobin: HemorphinsEuropean Journal of Pharmacology, 1986
- 252Cf‐Plasma Desorption Mass SpectrometryMass Spectrometry Reviews, 1985
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- 2 Inhibitiors of Angiotensin-Converting EnzymeProgress in Medicinal Chemistry, 1980
- Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsBiochemistry, 1977
- Fate of Angiotensin I in the CirculationNature, 1968
- Conversion of Angiotensin I to Angiotensin IINature, 1967
- THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYMEThe Journal of Experimental Medicine, 1956